Blog: CORE LABORATORIES N V : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 2.02 Results of Operations and Financial Condition.

On July 27, 2022, Core Laboratories N.V. (the “Company”) issued a press release
announcing its financial results for the second quarter of 2022.

Item 7.01 Regulation FD Disclosure.

On July 27, 2022, Core Laboratories N.V. issued a press release announcing a
quarterly cash dividend of $0.01 per share of common stock for shareholders of
record on August 8, 2022 and payable August 29, 2022.

The full text of the press release is set forth in Exhibit 99.1 attached hereto.

The information in this Report and the exhibit attached hereto shall not be
deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the “Exchange Act”), nor shall they be deemed incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly stated by specific reference in such
filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Press release issued on July 27, 2022 *

104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

* This exhibit is intended to be furnished and shall not be deemed “filed” for
purposes of the Exchange Act.

——————————————————————————–

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s